104 related articles for article (PubMed ID: 24885428)
1. Demographic relevancy of increased use of assisted reproduction in European countries.
Kocourkova J; Burcin B; Kucera T
Reprod Health; 2014 May; 11():37. PubMed ID: 24885428
[TBL] [Abstract][Full Text] [Related]
2. Cultural determinants influence assisted reproduction usage in Europe more than economic and demographic factors.
Präg P; Mills MC
Hum Reprod; 2017 Nov; 32(11):2305-2314. PubMed ID: 29040579
[TBL] [Abstract][Full Text] [Related]
3. The Association between Assisted Reproduction Technology (ART) and Social Perception of Childbearing Deadline Ages: A Cross-Country Examination of Selected EU Countries.
Kim EJ; Cho MJ
Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33671523
[TBL] [Abstract][Full Text] [Related]
4. Associations between maternal older age, family environment and parent and child wellbeing in families using assisted reproductive techniques to conceive.
Boivin J; Rice F; Hay D; Harold G; Lewis A; van den Bree MM; Thapar A
Soc Sci Med; 2009 Jun; 68(11):1948-55. PubMed ID: 19346045
[TBL] [Abstract][Full Text] [Related]
5. The reproductive journeys of French women over 40 seeking assisted reproductive technology treatments in Spain.
Desy A; Marre D
Soc Sci Med; 2024 Jun; 351():116951. PubMed ID: 38743990
[TBL] [Abstract][Full Text] [Related]
6. Reproduction beyond menopause: how old is too old for assisted reproductive technology?
Banh D; Havemann DL; Phelps JY
J Assist Reprod Genet; 2010 Jul; 27(7):365-70. PubMed ID: 20454846
[TBL] [Abstract][Full Text] [Related]
7. An alternative to sexual reproduction: artificial gametes and their implications for society.
Smajdor A
Br Med Bull; 2019 Mar; 129(1):5-11. PubMed ID: 30753441
[TBL] [Abstract][Full Text] [Related]
8. Change in the perceived reproductive age window and delayed fertility in Europe.
Lazzari E; Compans MC; Beaujouan E
Popul Stud (Camb); 2024 Mar; ():1-21. PubMed ID: 38426944
[TBL] [Abstract][Full Text] [Related]
9. Explaining fertility transition of a developing country: an analysis of quantum and tempo effect.
Fazle Rabbi AM; Kabir M
Fertil Res Pract; 2015; 1():4. PubMed ID: 28620509
[TBL] [Abstract][Full Text] [Related]
10. EuMAR: a roadmap towards a prospective, cycle-by-cycle registry of medically assisted reproduction in Europe.
De Geyter C; Calhaz-Jorge C; Goossens V; Magli CM; Smeenk J; Vesela K; Vermeulen N; Wyns C
Hum Reprod Open; 2023; 2023(2):hoad011. PubMed ID: 37113274
[TBL] [Abstract][Full Text] [Related]
11. New choreographies of inequalities in reproduction: an overview of assisted reproduction market.
Garcia SM
JBRA Assist Reprod; 2023 Sep; 27(4):739-46. PubMed ID: 37768815
[TBL] [Abstract][Full Text] [Related]
12. The impact of infertility: why ART should be a higher priority for women in the global South.
Fleetwood A; Campo-Engelstein L
Cancer Treat Res; 2010; 156():237-48. PubMed ID: 20811838
[No Abstract] [Full Text] [Related]
13. The ART clock: Temporal limits to assisted reproduction.
Jacobson H
Reprod Biomed Soc Online; 2022 Mar; 14():144-155. PubMed ID: 35024471
[TBL] [Abstract][Full Text] [Related]
14. The optimal design of assisted reproductive technologies policies.
Leroux ML; Pestieau P; Ponthiere G
Health Econ; 2024 Jul; 33(7):1454-1479. PubMed ID: 38475875
[TBL] [Abstract][Full Text] [Related]
15. Microbiome in Reproduction: Analysis Methods, Novel Techniques, and State-of-the-Art in Female Reproductive Health.
Altmäe S
Semin Reprod Med; 2023 Sep; 41(5):121-124. PubMed ID: 38320575
[No Abstract] [Full Text] [Related]
16. Unravelling orders in a borderless Europe? Cross-border reproductive care and the paradoxes of assisted reproductive technology policy in Germany and Poland.
Wilson TL
Reprod Biomed Soc Online; 2016 Dec; 3():48-59. PubMed ID: 29774250
[TBL] [Abstract][Full Text] [Related]
17. Use of medication in pregnancy on the rise: Study on 1.4 million Danish pregnancies from 1998 to 2018.
Thunbo MØ; Vendelbo JH; Witte DR; Larsen A; Pedersen LH
Acta Obstet Gynecol Scand; 2024 Jun; 103(6):1210-1223. PubMed ID: 38491733
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of recombinant human granulocyte colony-stimulating factor in patients with poor ovarian response: protocol for a multicentre, randomised, controlled trial.
Zeng X; Du L; Yang H; Wang F
BMJ Open; 2023 Dec; 13(12):e074135. PubMed ID: 38159964
[TBL] [Abstract][Full Text] [Related]
19. Does information on age-related fertility decline and fertility policies affect university students' family and career expectations? Evidence from a randomized controlled trial.
Tan PL; Pan J; Xia X
PLoS One; 2023; 18(11):e0287526. PubMed ID: 37910460
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Artificial Oocyte Activation in Improving the Reproductive Outcome in Poor Responders: A Single Centre Cohort Study.
Kaur B; Malik S; Prakash V; Bhatia V; Gupta D
J Family Reprod Health; 2023 Mar; 17(1):45-53. PubMed ID: 37538231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
